RecruitingInfluenza
A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults
Eligible age
18+ yrs
Accepts
All genders
Locations
10 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to evaluate humoral immunogenicity after 2 doses of mRNA-1018-H5, and to evaluate the safety and reactogenicity of mRNA-1018-H5 in adults ≥18 years of age.
Sponsor: ModernaTX, Inc.
Where it's recruiting
California
San Bernardino
Georgia
Savannah
Idaho
Meridian
Maryland
Rockville
Nebraska
Omaha
Ohio
Beachwood
Rhode Island
East Greenwich
South Carolina
Anderson
Texas
Dallas
Virginia
Suffolk
Source: ClinicalTrials.gov · NCT07496450 · last updated 2026-04-03